REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Raymed Labs Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Raymed Labs Ltd. Profile Updated: November 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Raymed Labs Ltd. operates as a pharmaceutical company. The company naufactures Allophatic Medicines such as RAMPICILLIN, RAMPICLOX, RAMPIMOX, RAMYKACIN, OXYTETRACYCLINE, etc. Incorporated in the year 1992, Raymed Labs Ltd. has its office located in Saharanpur.

Legal Address
103 Emperor 1,, Supertech Emerald Court, Sector-93A
Noida; Uttar Pradesh; Postal Code: 201304

Contact Details: Purchase the Raymed Labs Ltd. report to view the information.

Website: http://www.raymedlab.com

Basic Information
Total Employees:
Purchase the Raymed Labs Ltd. report to view the information.
Outstanding Shares:
Purchase the Raymed Labs Ltd. report to view the information.
Registered Capital:
Purchase the Raymed Labs Ltd. report to view the information.
Financial Auditors:
Purchase the Raymed Labs Ltd. report to view the information.
Incorporation Date:
1992
Key Executives
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
WholeTime Director & CFO
Purchase this report to view the information.
Co. Secretary & Compl. Officer
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
47.9%
Purchase this report to view the information.
28.36%
Purchase this report to view the information.
22.78%
Purchase this report to view the information.
0.96%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Raymed Labs Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-26.58%▼
Net Profit (Loss) for the Period
-26.58%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo